New onset diabetes, type 1 diabetes and COVID-19.
New onset diabetes, type 1 diabetes and COVID-19.
复制标题
DOI:
10.1016/j.dsx.2020.11.012
复制
发表时间:
2020-11
期刊:
影响因子:
--
通讯作者:
Kuchay MS
中科院分区:
文献类型:
--
作者:
Boddu SK;Aurangabadkar G;Kuchay MS
New data has emerged regarding higher risk of coronavirus disease 2019 (COVID-19), and its severity and complications in patients with type 2 diabetes mellitus (T2DM). However, there is a dearth of evidence regarding type 1 diabetes mellitus (T1DM). This article explores the possibility of COVID 19 induced diabetes and highlights a potential bidirectional link between COVID 19 and T1DM. A literature search was performed with Medline (PubMed), Scopus, and Google Scholar electronic databases till October 2020, using relevant keywords (COVID-19 induced diabetes; COVID-19 and type 1 diabetes; COVID-19 induced DKA; new-onset diabetes after SARS-CoV-2 infection) to extract relevant studies describing relationship between COVID-19 and T1DM. Past lessons and new data teach us that severe acute respiratory syndrome coronaviruses (SARS-CoV and SARS-CoV-2) can enter islet cells via angiotensin converting enzyme-2 (ACE-2) receptors and cause reversible β-cell damage and transient hyperglycemia. There have been postulations regarding the potential new-onset T1DM triggered by COVID-19. This article reviews the available evidence regarding the impact and interlink between COVID-19 and Τ1DM. We also explore the mechanisms behind the viral etiology of Τ1DM. SARS-CoV-2 can trigger severe diabetic ketoacidosis at presentation in individuals with new-onset diabetes. However, at present, there is no hard evidence that SARS-CoV-2 induces T1DM on it’s own accord. Long term follow-up of children and adults presenting with new-onset diabetes during this pandemic is required to fully understand the type of diabetes induced by COVID-19. Covid-19 related mortality is significantly higher not only in people with type 2 diabetes, but also in type 1 diabetes. ACE2 is abundantly expressed in pancreatic islet cells which SARS CoV2 utilises as point of entry into the cells. We review all the available evidence regarding among COVID-19 and new-onset diabetes and type 1 diabetes mellitus. .
登录
查看更多内容
影响因子:
5
作者:
Bode, Bruce;Garrett, Valerie;Klonoff, David C.
通讯作者:
Klonoff, David C.
影响因子:
3.6
作者:
Hadi, Amer;Werge, Mikkel;Gluud, Lise Lotte
通讯作者:
Gluud, Lise Lotte
影响因子:
44.5
作者:
Holman, Naomi;Knighton, Peter;Valabhji, Jonathan
通讯作者:
Valabhji, Jonathan
影响因子:
7.3
作者:
Hamming, I;Timens, W;van Goor, H
通讯作者:
van Goor, H
影响因子:
7.7
作者:
Filippi, Christophe M.;von Herrath, Matthias G.
通讯作者:
von Herrath, Matthias G.